The Neuroscience of Psilocybin: How It Works in the Brain

Psilocybin has been used ceremonially for centuries, but only in the last two decades has neuroscience developed tools sophisticated enough to observe what it actually does inside the brain. The findings have surprised researchers and reshaped understanding of consciousness, depression, and what therapeutic change looks like at the level of neural tissue.

From Mushroom to Molecule: Basic Pharmacology

When psilocybin is ingested, it is rapidly dephosphorylated in the gut and liver by alkaline phosphatase enzymes, converting it to psilocin — the active compound. This conversion happens within 20–40 minutes, which corresponds to the onset of effects. Psilocin closely resembles serotonin in molecular structure and binds with high affinity to serotonin receptors throughout the brain, most significantly the 5-HT2A subtype.

5-HT2A receptors are densely expressed in the prefrontal cortex, the outermost layer of the brain most associated with complex cognition, self-reflection, and emotional regulation. Activation of these receptors is the primary trigger for the cascade of neurobiological changes that follow.

Default Mode Network Suppression

One of the most replicated findings in psilocybin neuroscience is its dramatic suppression of the Default Mode Network (DMN). The DMN is a set of interconnected brain regions — including the medial prefrontal cortex, posterior cingulate cortex, and angular gyrus — that are active during mind-wandering, self-referential thought, rumination, and the construction of our sense of "self" as a continuous entity through time.

In depression, the DMN is chronically overactive. Depressed individuals spend disproportionate mental time in self-focused negative rumination, a pattern that both reflects and reinforces the disorder.

Functional MRI studies from the Imperial College London group (Carhart-Harris et al.) showed that psilocybin produces robust suppression of DMN activity that correlates directly with the subjective sense of "ego dissolution" — the temporary dissolution of ordinary self-boundaries. This suppression also correlates with therapeutic outcomes: patients whose DMN was most disrupted showed the greatest reductions in depression at follow-up.

Global Brain Connectivity and Entropy

Psilocybin does not merely suppress one network — it fundamentally reorganizes communication patterns across the entire brain. Under normal conditions, brain activity is organized into constrained, predictable patterns. During psilocybin effects, these constraints loosen dramatically.

Carhart-Harris and colleagues proposed the "entropic brain hypothesis": psilocybin increases the entropy (complexity, unpredictability) of brain activity, allowing the brain to access states and connections it typically suppresses. Regions that do not ordinarily communicate with each other form novel transient connections. This "global brain connectivity" increase is thought to underlie the sense of expanded perception, novel insights, and the feeling that previously fixed mental patterns have become fluid and reorganizable.

In a clinical context, this is understood as opening a window of enhanced neuroplasticity — a period when deeply entrenched patterns of thought and behavior may be more amenable to change.

BDNF and Synaptogenesis

Beyond activity patterns, psilocybin produces structural changes in the brain. Research from multiple groups has documented that psilocybin and psilocin increase the expression of brain-derived neurotrophic factor (BDNF), often called "fertilizer for neurons." BDNF promotes the growth of new synaptic connections (synaptogenesis) and supports the survival of existing neurons.

Preclinical studies from Yale and other institutions have shown that psilocin promotes dendritic spine growth — the small protrusions on neurons where synaptic connections form — within 24 hours of a single dose, and that these structural changes persist for weeks. In animal models of depression (which involve chronic stress-induced pruning of synaptic connections in the prefrontal cortex), psilocybin restored spine density toward normal levels.

This mechanism may explain why psilocybin's therapeutic effects outlast its pharmacological presence in the body: the drug triggers structural brain changes that persist independently.

Thalamocortical Gating

Under ordinary conditions, the thalamus acts as a gatekeeper, filtering sensory information before it reaches cortical awareness. This "gating" prevents the brain from being overwhelmed by the constant flood of sensory data it receives. Psilocybin appears to disrupt this filtering mechanism, allowing more sensory and associative information to reach conscious awareness simultaneously.

This may account for the perceptual intensification experienced during psilocybin sessions — heightened color, sound sensitivity, synesthetic experiences — and may also contribute to the sense of novelty and significance that characterizes the psychedelic state.

Cortical Thickness and Structural Changes

Beyond acute effects, longer-term structural brain changes have been documented in regular psilocybin users and in clinical trial participants. MRI studies have found increased cortical thickness in regions associated with attention and sensory processing, and changes in white matter connectivity. Whether these represent beneficial neuroplastic adaptation or require careful monitoring is an active area of research.

Connecting Mechanism to Therapeutic Effect

The neuroscience of psilocybin provides a plausible biological account of its therapeutic effects. DMN suppression interrupts chronic rumination. Increased global connectivity allows new perspectives and associations to form. BDNF-driven synaptogenesis may rebuild prefrontal circuits damaged by chronic stress and depression. The thalamocortical disruption enables the intensity of experience that seems, paradoxically, to make the session therapeutically meaningful.

Researchers are careful to note that neuromechanistic explanations, while illuminating, do not fully account for the role of the psychological experience, the therapeutic relationship, and the integration work that follows. Psilocybin appears to act on the brain and through the mind simultaneously — and the most effective therapeutic frameworks engage both.

This content is educational. Consult a medical professional for any health or treatment decisions.